Journal of Nuclear Medicine Vol. 46 No. 12 7a-8a
© 2005 by Society of Nuclear Medicine
THIS MONTH IN JNM
Wester and Kessler review evidence supporting the promise of polyvalent 
vß3-integrin antagonists, such as peptide multimers and peptide-polymer conjugates, as ligands for use in radiotherapeutic targeting of integrins involved in angiogenesis.
Page 1940
Boswell and Brechbiel outline the rationale for the utility of a new class of trifunctional somatostatin analogs (described elsewhere in this issue) that are transported into both targeted tumor cells and into the nuclei, where Auger electrons are most lethal.
Page 1946
Jacobs and colleagues compare the diagnostic effectiveness of 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in primary central nervous system tumors.
Page 1948
Lopresti and colleagues describe simplified methods for analysis of retention of the amyloid-binding Pittsburgh Compound in PET imaging in patients with Alzheimer’s disease and in healthy individuals.
Page 1959
Yamauchi and colleagues use 11C-flumazenil PET to measure benzodiazepine receptors to determine whether selective neuronal damage is associated with border-zone infarction in internal carotid artery occlusive disease.
Page 1973
Costes and colleagues describe the binding potential of 18F-MPPF, a novel serotonin 5-HT1A antagonist PET tracer with promise in serotoninergic system imaging, and discuss the importance of a robust normative database for additional research.
Page 1980
Heston and Sigg quantify the relative contributions of end-diastolic and end-systolic volumes to an optimized stress-induced volume ratio in patents undergoing gated SPECT imaging for myocardial ischemia.
Page 1990
Pellegrino and colleagues assess the relationship between brachial artery flow–mediated dilation and coronary flow reserve as estimated by sestamibi imaging in patients with peripheral artery disease.
Page 1997
Elhendy and colleagues investigate whether stress 99mTc-tetrofosmin myocardial perfusion imaging can independently provide information for predicting mortality in patients with stable angina pectoris.
Page 2003
Khorsand and colleagues evaluate myocardial electrocardiography-gated 13N-ammonia PET in the simultaneous assessment of myocardial perfusion, left ventricular geometry, and contractile function.
Page 2090
Bleeker-Rovers and colleagues assess the value of 18F-FDG PET imaging in detecting metastatic infectious foci in patients with bacteremia or fungemia at high risk of metastatic infection.
Page 2014
Lejeune and colleagues use a decision analysis model to compare the cost effectiveness within the French health care system of CT with and without PET in the diagnosis and staging of patients with metachronous liver metastases of colorectal cancer.
Page 2020
Wieder and colleagues evaluate chemotherapy-induced changes in tumor glucose use and tumor size in patients with adenocarcinoma of the esophagogastric junction undergoing 18F-FDG PET and CT imaging before, during, and after neoadjuvant chemotherapy.
Page 2029
Boersma and colleagues review the clinical relevance, limitations, and potential applications of visualizing apoptosis with the programmed cell–detecting protein annexin A5.
Page 2035
Hartung and colleagues explore the effects of dietary modification and statin therapy (measures known to favorably influence outcomes in coronary disease) on apoptosis in experimental atherosclerotic lesions.
Page 2051
Verwijnen and colleagues compare the renal uptake effects of oral and intravenous administration of D-lysine in rats injected with 111In- DTPA-octreotide, in an effort to surmount current limitations in tumor therapy with radiolabeled somatostatin analogs.
Page 2057
Bäck and colleagues investigate the relative biological effectiveness of the -emitter 211At and that of 60Co 
-irradiation in a mouse radioimmunotherapy model of intraperitoneal ovarian cancer.
Page 2061
Buursma and colleagues evaluate the feasibility of monitoring gene therapy with the human norepinephrine transporter as a reporter gene in combination with the reporter probe 11C-m-hydroxyephedrine in PET imaging.
Page 2068
Essman and colleagues determine the distribution of 153Sm-EDTMP, a focus of interest in the treatment of primary osteosarcoma, within the tibias of juvenile rabbits and estimate the radiation-absorbed doses delivered to the physeal cartilage.
Page 2076
Brambilla and colleagues report the results of performance measurements for the lutetium oxyorthosilicate–based whole-body PET/CT scanner Biograph 16 HI-REZ using the National Electrical Manufacturers Association NU 2-2001 standard.
Page 2083
Boecker and colleagues quantify the binding kinetics of the novel PET tracer 18F-FDPN for opiodergic system imaging and assess the effects of scanning duration in an effort to determine an optimal protocol.
Page 2092
Ginj and colleagues report on the design, synthesis, and preclinical assessment of new trifunctional conjugates of somatostatin that target the nucleus to provide a better carrier for Auger electron–emitting radionuclides and ensure longer retention in tumor cells.
Page 2097
Kersemans and colleagues describe and evaluate the tumor-detecting characteristics and kinetics of 123/125I-2-iodo-D-phenylalanine, a radiolabeled amino acid analog with promise in diagnostic imaging.
Page 2104
Brogsitter and colleagues investigate whether intraarterial application of 131I-MIBG has the potential to enhance tumor uptake in a population of patients with primary or metastasized neuroendocrine tumors.
Page 2112
| ON THE COVER
The newly developed 18F-FLT PET is compared with the routinely used 11C-MET PET and contrast-enhanced MRI in these images of a 26-y-old woman with a WHO grade I astrocytoma. The findings illustrate the ability of 18F-FLT PET to determine DNA metabolism and amino acid uptake, as well as the integrity of the blood–brain barrier, in patients with gliomas and clarify the role of 18F-FLT in the diagnosis of primary central nervous system tumors.
|
Related articles in JNM:
- Molecular Targeting with Peptides or Peptide-Polymer Conjugates: Just a Question of Size?
- Hans-Jürgen Wester and Horst Kessler
JNM 2005 46: 1940-1945.
[Full Text]
- Auger Electrons: Lethal, Low Energy, and Coming Soon to a Tumor Cell Nucleus Near You
- C. Andrew Boswell and Martin W. Brechbiel
JNM 2005 46: 1946-1947.
[Full Text]
- 18F-Fluoro-L-Thymidine and 11C-Methylmethionine as Markers of Increased Transport and Proliferation in Brain Tumors
- Andreas H. Jacobs, Anne Thomas, Lutz W. Kracht, Huongfeng Li, Claus Dittmar, Guido Garlip, Norbert Galldiks, Johannes C. Klein, Jan Sobesky, Rüdiger Hilker, Stefan Vollmar, Karl Herholz, Klaus Wienhard, and Wolf-Dieter Heiss
JNM 2005 46: 1948-1958.
[Abstract]
[Full Text]
- Simplified Quantification of Pittsburgh Compound B Amyloid Imaging PET Studies: A Comparative Analysis
- Brian J. Lopresti, William E. Klunk, Chester A. Mathis, Jessica A. Hoge, Scott K. Ziolko, Xueling Lu, Carolyn C. Meltzer, Kurt Schimmel, Nicholas D. Tsopelas, Steven T. DeKosky, and Julie C. Price
JNM 2005 46: 1959-1972.
[Abstract]
[Full Text]
- Selective Neuronal Damage and Borderzone Infarction in Carotid Artery Occlusive Disease: A 11C-Flumazenil PET Study
- Hiroshi Yamauchi, Takashi Kudoh, Yoshihiko Kishibe, Jinei Iwasaki, and Shinya Kagawa
JNM 2005 46: 1973-1979.
[Abstract]
[Full Text]
- A 18F-MPPF PET Normative Database of 5-HT1A Receptor Binding in Men and Women Over Aging
- Nicolas Costes, Isabelle Merlet, Karine Ostrowsky, Isabelle Faillenot, Franck Lavenne, Luc Zimmer, Philippe Ryvlin, and Didier Le Bars
JNM 2005 46: 1980-1989.
[Abstract]
[Full Text]
- Quantifying Transient Ischemic Dilation Using Gated SPECT
- Thomas F. Heston and Daniel M. Sigg
JNM 2005 46: 1990-1996.
[Abstract]
[Full Text]
- Relationship Between Brachial Artery Flow–Mediated Dilation and Coronary Flow Reserve in Patients with Peripheral Artery Disease
- Teresa Pellegrino, Giovanni Storto, Pasquale Perrone Filardi, Anna Rita Sorrentino, Antonio Silvestro, Mario Petretta, Gregorio Brevetti, Massimo Chiariello, Marco Salvatore, and Alberto Cuocolo
JNM 2005 46: 1997-2002.
[Abstract]
[Full Text]
- Risk Stratification of Patients with Angina Pectoris by Stress 99mTc-Tetrofosmin Myocardial Perfusion Imaging
- Abdou Elhendy, Arend F.L. Schinkel, Ron T. van Domburg, Jeroen J. Bax, Roelf Valkema, Aukje Huurman, Harm H. Feringa, and Don Poldermans
JNM 2005 46: 2003-2008.
[Abstract]
[Full Text]
- Gated Cardiac 13N-NH3 PET for Assessment of Left Ventricular Volumes, Mass, and Ejection Fraction: Comparison with Electrocardiography-Gated 18F-FDG PET
- Aliasghar Khorsand, Senta Graf, Harald Eidherr, Wolfgang Wadsak, Kurt Kletter, Heinz Sochor, Ernst Schuster, and Gerold Porenta
JNM 2005 46: 2009-2013.
[Abstract]
[Full Text]
- 18F-FDG PET in Detecting Metastatic Infectious Disease
- Chantal P. Bleeker-Rovers, Fidel J. Vos, Geert J.A. Wanten, Jos W.M. van der Meer, Frans H.M. Corstens, Bart-Jan Kullberg, and Wim J.G. Oyen
JNM 2005 46: 2014-2019.
[Abstract]
[Full Text]
- Use of a Decision Analysis Model to Assess the Cost-Effectiveness of 18F-FDG PET in the Management of Metachronous Liver Metastases of Colorectal Cancer
- Catherine Lejeune, Marie J. Bismuth, Thierry Conroy, Catherine Zanni, Pierre Bey, Laurent Bedenne, Jean Faivre, Patrick Arveux, and Francis Guillemin
JNM 2005 46: 2020-2028.
[Abstract]
[Full Text]
- Comparison of Changes in Tumor Metabolic Activity and Tumor Size During Chemotherapy of Adenocarcinomas of the Esophagogastric Junction
- Hinrich A. Wieder, Ambros J. Beer, Florian Lordick, Katja Ott, Michael Fischer, Ernst J. Rummeny, Sibylle Ziegler, Jörg R. Siewer, Markus Schwaiger, and Wolfgang A. Weber
JNM 2005 46: 2029-2034.
[Abstract]
[Full Text]
- Past, Present, and Future of Annexin A5: From Protein Discovery to Clinical Applications
- Hendrikus H. Boersma, Bas L.J.H. Kietselaer, Leo M.L. Stolk, Abdelkader Bennaghmouch, Leonard Hofstra, Jagat Narula, Guido A.K. Heidendal, and Chris P.M. Reutelingsperger
JNM 2005 46: 2035-2050.
[Abstract]
[Full Text]
- Resolution of Apoptosis in Atherosclerotic Plaque by Dietary Modification and Statin Therapy
- Dagmar Hartung, Masayoshi Sarai, Artiom Petrov, Frank Kolodgie, Navneet Narula, Johan Verjans, Renu Virmani, Chris Reutelingsperger, Leo Hofstra, and Jagat Narula
JNM 2005 46: 2051-2056.
[Abstract]
[Full Text]
- Oral Versus Intravenous Administration of Lysine: Equal Effectiveness in Reduction of Renal Uptake of [111In-DTPA]Octreotide
- Suzanne M. Verwijnen, Eric P. Krenning, Roelf Valkema, Jan G.M. Huijmans, and Marion de Jong
JNM 2005 46: 2057-2060.
[Abstract]
[Full Text]
- 211At Radioimmunotherapy of Subcutaneous Human Ovarian Cancer Xenografts: Evaluation of Relative Biologic Effectiveness of an -Emitter In Vivo
- Tom Bäck, Håkan Andersson, Chaitanya R. Divgi, Ragnar Hultborn, Holger Jensen, Sture Lindegren, Stig Palm, and Lars Jacobsson
JNM 2005 46: 2061-2067.
[Abstract]
[Full Text]
- The Human Norepinephrine Transporter in Combination with 11C-m-Hydroxyephedrine as a Reporter Gene/Reporter Probe for PET of Gene Therapy
- Anne Rixt Buursma, Antoine M.J. Beerens, Erik F.J. de Vries, Aren van Waarde, Marianne G. Rots, Geke A.P. Hospers, Willem Vaalburg, and Hidde J. Haisma
JNM 2005 46: 2068-2075.
[Abstract]
[Full Text]
- Intraorgan Biodistribution and Dosimetry of 153Sm-Ethylenediaminetetramethylene Phosphonate in Juvenile Rabbit Tibia: Implications for Targeted Radiotherapy of Osteosarcoma
- Stephanie C. Essman, Michael R. Lewis, and William H. Miller
JNM 2005 46: 2076-2082.
[Abstract]
[Full Text]
- Performance Characteristics Obtained for a New 3-Dimensional Lutetium Oxyorthosilicate–Based Whole-Body PET/CT Scanner with the National Electrical Manufacturers Association NU 2-2001 Standard
- Marco Brambilla, Chiara Secco, Marco Dominietto, Roberta Matheoud, Gianmauro Sacchetti, and Eugenio Inglese
JNM 2005 46: 2083-2091.
[Abstract]
[Full Text]
- Optimal Duration of PET Studies with 18F-Fluoroethyl-Diprenorphine
- Henning Boecker, Till Sprenger, Gjermund Henriksen, Thomas R. Toelle, and Mary E. Spilker
JNM 2005 46: 2092-2096.
[Abstract]
[Full Text]
- Trifunctional Somatostatin-Based Derivatives Designed for Targeted Radiotherapy Using Auger Electron Emitters
- Mihaela Ginj, Karin Hinni, Sibylle Tschumi, Stefan Schulz, and Helmut R. Maecke
JNM 2005 46: 2097-2103.
[Abstract]
[Full Text]
- In Vivo Evaluation and Dosimetry of 123I-2-Iodo-D-Phenylalanine, a New Potential Tumor-Specific Tracer for SPECT, in an R1M Rhabdomyosarcoma Athymic Mouse Model
- Veerle Kersemans, Bart Cornelissen, Klaus Bacher, Ken Kersemans, Hubert Thierens, Rudi A. Dierckx, Bart De Spiegeleer, Guido Slegers, and John Mertens
JNM 2005 46: 2104-2111.
[Abstract]
[Full Text]
- Enhanced Tumor Uptake in Neuroendocrine Tumors After Intraarterial Application of 131I-MIBG
- Claudia Brogsitter, Jörg Pinkert, Jan Bredow, Thomas Kittner, and Jörg Kotzerke
JNM 2005 46: 2112-2116.
[Abstract]
[Full Text]
